Cargando…
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review
BACKGROUND: More information is needed about possible associations between the newer anti-epileptic drugs (AEDs) in the first trimester of pregnancy and specific congenital anomalies of the fetus. OBJECTIVES: We performed a literature review to find signals for potential associations between newer A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914544/ https://www.ncbi.nlm.nih.gov/pubmed/27398292 http://dx.doi.org/10.1007/s40801-016-0078-1 |
_version_ | 1782438568993488896 |
---|---|
author | de Jong, Josta Garne, Ester de Jong-van den Berg, Lolkje T. W. Wang, Hao |
author_facet | de Jong, Josta Garne, Ester de Jong-van den Berg, Lolkje T. W. Wang, Hao |
author_sort | de Jong, Josta |
collection | PubMed |
description | BACKGROUND: More information is needed about possible associations between the newer anti-epileptic drugs (AEDs) in the first trimester of pregnancy and specific congenital anomalies of the fetus. OBJECTIVES: We performed a literature review to find signals for potential associations between newer AEDs (lamotrigine, topiramate, levetiracetam, gabapentin, oxcarbazepine, eslicarbazepine, felbamate, lacosamide, pregabalin, retigabine, rufinamide, stiripentol, tiagabine, vigabatrin, and zonisamide) and specific congenital anomalies. METHODS: We searched PubMed and EMBASE to find observational studies with pregnancies exposed to newer AEDs and detailed information on congenital anomalies. The congenital anomalies in the studies were classified according to the congenital anomaly subgroups of European Surveillance of Congenital Anomalies (EUROCAT). We compared the prevalence of specific congenital anomalies in fetuses exposed to individual AEDs in the combined studies with that of the general population in a reference database. A significantly higher prevalence based on three or more fetuses with anomalies was considered a signal. RESULTS: Topiramate showed a higher rate of congenital anomalies than the other newer AEDs. Four signals were found. The signals for associations between topiramate and cleft lip with/without cleft palate and hypospadias were considered strong. Associations between lamotrigine and anencephaly and transposition of great vessels were found within one study and were not supported by other studies. No signals were found for the other newer AEDs, or the information was too limited to provide such a signal. CONCLUSION: In terms of associations between monotherapy with a newer AED in the first trimester of pregnancy and a specific congenital anomaly, the signals for topiramate and cleft lip with/without cleft palate and hypospadias should be investigated further. |
format | Online Article Text |
id | pubmed-4914544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-49145442016-07-06 The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review de Jong, Josta Garne, Ester de Jong-van den Berg, Lolkje T. W. Wang, Hao Drugs Real World Outcomes Review Article BACKGROUND: More information is needed about possible associations between the newer anti-epileptic drugs (AEDs) in the first trimester of pregnancy and specific congenital anomalies of the fetus. OBJECTIVES: We performed a literature review to find signals for potential associations between newer AEDs (lamotrigine, topiramate, levetiracetam, gabapentin, oxcarbazepine, eslicarbazepine, felbamate, lacosamide, pregabalin, retigabine, rufinamide, stiripentol, tiagabine, vigabatrin, and zonisamide) and specific congenital anomalies. METHODS: We searched PubMed and EMBASE to find observational studies with pregnancies exposed to newer AEDs and detailed information on congenital anomalies. The congenital anomalies in the studies were classified according to the congenital anomaly subgroups of European Surveillance of Congenital Anomalies (EUROCAT). We compared the prevalence of specific congenital anomalies in fetuses exposed to individual AEDs in the combined studies with that of the general population in a reference database. A significantly higher prevalence based on three or more fetuses with anomalies was considered a signal. RESULTS: Topiramate showed a higher rate of congenital anomalies than the other newer AEDs. Four signals were found. The signals for associations between topiramate and cleft lip with/without cleft palate and hypospadias were considered strong. Associations between lamotrigine and anencephaly and transposition of great vessels were found within one study and were not supported by other studies. No signals were found for the other newer AEDs, or the information was too limited to provide such a signal. CONCLUSION: In terms of associations between monotherapy with a newer AED in the first trimester of pregnancy and a specific congenital anomaly, the signals for topiramate and cleft lip with/without cleft palate and hypospadias should be investigated further. Springer International Publishing 2016-05-24 /pmc/articles/PMC4914544/ /pubmed/27398292 http://dx.doi.org/10.1007/s40801-016-0078-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article de Jong, Josta Garne, Ester de Jong-van den Berg, Lolkje T. W. Wang, Hao The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title | The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title_full | The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title_fullStr | The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title_full_unstemmed | The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title_short | The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review |
title_sort | risk of specific congenital anomalies in relation to newer antiepileptic drugs: a literature review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914544/ https://www.ncbi.nlm.nih.gov/pubmed/27398292 http://dx.doi.org/10.1007/s40801-016-0078-1 |
work_keys_str_mv | AT dejongjosta theriskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT garneester theriskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT dejongvandenberglolkjetw theriskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT wanghao theriskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT dejongjosta riskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT garneester riskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT dejongvandenberglolkjetw riskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview AT wanghao riskofspecificcongenitalanomaliesinrelationtonewerantiepilepticdrugsaliteraturereview |